InvestorsHub Logo
icon url

olden_grumpini

05/10/21 4:13 PM

#358749 RE: Lemoncat #358746

Would be good to know what "Non-clinical phase" under the column heading "Development stage at time of guidance" means. 21 of the treatments listed fall into this category.

I also find it interesting that Ivermectin is not on this list while chloroquine and Chloroquine and hydroxychloroquine cyclops DPI are.
icon url

greatimes

05/10/21 5:56 PM

#358757 RE: Lemoncat #358746


How would Remdesivir become the SOC in the United States? One of the most expensive and least effective treatments for COVID.
icon url

loanranger

05/10/21 9:08 PM

#358761 RE: Lemoncat #358746

"B-COVID likely has not received EMA advice and obviously does not have ongoing clinical trials in the EU."

But it could...
Ireland has been a member state of the European Union since 1973.

And the Company laid the groundwork there 2 years ago for the reasons stated.
"On February 15, 2019, the Company formed IPIX Pharma Limited (“IPIX Pharma”), a wholly-owned subsidiary incorporated under the Companies Act 2014 of Ireland. IPIX Pharma is a Private Company Limited by Shares. The subsidiary will serve as a key hub for strategic collaboration with European companies and medical communities in addition to providing cost-saving efficiencies and flexibility with respect to developing Brilacidin under European Medicines Agency standards."

Maybe this is the problem:
Next Annual Return
15/08/2020